Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Long-term usage of glucocorticoids results in a loss of bone mass and a higher risk of fracture, and the most common cause of secondary osteoporosis is glucocorticoid-induced osteoporosis (GIOP). For preventing GIOP, bisphosphonate (BP) is widely used. However, analysis on BP's effect on the prevention of re-fracture is insufficient. The purpose of the present study is to evaluate the comparative treatment effect and prevention of re-fracture according to the type of BP in GIOP as the basis for a reliable clinical strategy for patients.
Methods And Analysis: We will search electronic databases of the PubMed, Cochrane Library and EMBASE using a comprehensive search strategy in December 2021 with no language restriction. Randomised controlled trials (RCTs), quasi-RCTs, controlled trials and cohort studies evaluating the effectiveness of BP to the patients with GIOP will be included in this study. The primary outcome will be the incidence of hip, vertebral and other fractures. The secondary outcome will include percentage changes on the bone mineral density and incidence of re-fracture. Assessing risk of bias for included studies is done using the Cochrane Risk of Bias tool and Risk Of Bias In Non-randomized Studies-of Intervention tool. If quantitative synthesis is possible, a meta-analysis will be performed. A subgroup analysis will be conducted to compare re-fracture rate on the patients with GIOP who experience previous fractures. This study's result will provide evidence for the effectiveness of BP in the prevention of re-fracture on patients with GIOP.
Ethics And Dissemination: The results will be disseminated through publishing in a peer-reviewed journal or public presentations. Ethical approval is not required as this is a systematic review of publicly available data.
Prospero Registration Number: CRD42022343787.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516213 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2022-062537 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The economic benefits of fracture prevention.
Expert Rev Pharmacoecon Outcomes Res
July 2025
Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Introduction: Osteoporosis-related fractures represent a significant and growing public health concern, especially in aging populations. Despite the availability of effective treatments, significant care gaps persist in both primary and secondary prevention.
Areas Covered: This narrative review synthesizes key findings from economic evaluations examining the cost-effectiveness of pharmacological and non-pharmacological therapies, fracture liaison services (FLS), and FRAX®-based intervention thresholds.
Objective: To systematically evaluate the risk factors of adjacent vertebral re-fracture after percutaneous vertebroplasty and percutaneous kyphoplasty for osteoporotic vertebral compression fractures.
Methods: PubMed, Embase, The Cochrane Library, Web of Science, CNKI, Wanfang, VIP, CBM and other databases were searched by computer to collect case-control studies on adjacent vertebral re-fracture after vertebroplasty for osteoporotic vertebral compression fractures. The retrieval time was from the establishment of the database to July 17,2024.
Prescribing outcomes following discharge from an osteoporosis specialist-led, post-fracture clinic: a prospective cohort study in Ontario, Canada.
Arch Osteoporos
June 2025
Division of Endocrinology and Metabolism, Western University, London, ON, Canada.
Unlabelled: We studied the effectiveness of an osteoporosis specialist-led post-fracture clinic on treatment and persistence with anti-osteoporosis medications in real-world patients. We found that 90% of study participants filled medications as prescribed, and 89% remained persistent with therapy. Our collaborative fracture model might be useful to other fracture centers.
View Article and Find Full Text PDFDevelopment and validation of a nomogram prediction model for osteoporotic vertebral compression re-fracture after percutaneous kyphoplasty based on lumbar local fat parameters.
Eur Spine J
April 2025
School of Medicine, Southeast University, Nanjing, China.
Objective: The aim of this study was to investigate the predictive value of lumbar local fat parameters for osteoporotic vertebral compression re-fracture (OVCRF) after percutaneous kyphoplasty (PKP) and to develop a nomogram that could provide novel strategies for the prevention of OVCRF.
Methods: We included patients who underwent PKP at Zhongda Hospital between January 2012 and December 2021. The cohort was randomly divided into training and validation cohorts in a 7:3 ratio.
Clinical effect analysis of unilateral percutaneous vertebral cement distribution in the repair of osteoporotic thoracolumbar vertebral compression fractures.
BMC Surg
March 2025
Minimally Invasive Spine Surgery, Sixth Afliated Hospital of Xinjiang Medical University, Orthopaedic Hospital of Xinjiang Uygur Autonomous Region, No.39 Wuxing Road, Urumqi, Xinjiang Uygur Autonomous Region, 830002, People's Republic of China.
Background: Osteoporotic vertebral fractures and their complications pose increasing risks to the elderly. The purpose of this study was to evaluate the clinical efficacy of unilateral percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures (OVCF) by assessing postoperative cement distribution.
Objective: This study aimed to investigate the impact of cement distribution on the efficacy of vertebral compression fracture repair to provide effective preventive and therapeutic measures, prevent postoperative vertebral re-fracture, and improve surgical outcomes.